Ngā hua rapu - Michelle A. Rudek

Whakamahine hua
  1. 1
    Use of antineoplastic agents in patients with cancer who have HIV/AIDS

    Use of antineoplastic agents in patients with cancer who have HIV/AIDS mā Michelle A. Rudek, Charles Flexner, Richard F. Ambinder

    I whakaputaina 2011
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Entinostat: a promising treatment option for patients with advanced breast cancer

    Entinostat: a promising treatment option for patients with advanced breast cancer mā Roisín M. Connolly, Michelle A. Rudek, Richard Piekarz

    I whakaputaina 2017
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Castration-Dependent Pharmacokinetics of Docetaxel in Patients With Prostate Cancer

    Castration-Dependent Pharmacokinetics of Docetaxel in Patients With Prostate Cancer mā Ryan M. Franke, Michael A. Carducci, Michelle A. Rudek, Sharyn D. Baker, Alex Sparreboom

    I whakaputaina 2010
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Plasma protein binding of sorafenib, a multi kinase inhibitor: in vitro and in cancer patients

    Plasma protein binding of sorafenib, a multi kinase inhibitor: in vitro and in cancer patients mā Maria Cristina Villarroel, Keith W. Pratz, Linping Xu, John J. Wright, B. Douglas Smith, Michelle A. Rudek

    I whakaputaina 2011
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Brain Penetration and Efficacy of Different Mebendazole Polymorphs in a Mouse Brain Tumor Model

    Brain Penetration and Efficacy of Different Mebendazole Polymorphs in a Mouse Brain Tumor Model mā Ren-Yuan Bai, Verena Staedtke, Teresia Wanjiku, Michelle A. Rudek, Avadhut D. Joshi, Gary L. Gallia, Gregory J. Riggins

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Interaction of the Multikinase Inhibitors Sorafenib and Sunitinib with Solute Carriers and ATP-Binding Cassette Transporters

    Interaction of the Multikinase Inhibitors Sorafenib and Sunitinib with Solute Carriers and ATP-Binding Cassette Transporters mā Shuiying Hu, Zhaoyuan Chen, Ryan M. Franke, Shelley Orwick, Ming Zhao, Michelle A. Rudek, Alex Sparreboom, Sharyn D. Baker

    I whakaputaina 2009
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    DNA methyltransferase inhibitor exposure–response: Challenges and opportunities

    DNA methyltransferase inhibitor exposure–response: Challenges and opportunities mā Amanda B. Kagan, Dominique A. Garrison, Nicole M. Anders, Jonathan Webster, Sharyn D. Baker, Srinivasan Yegnasubramanian, Michelle A. Rudek

    I whakaputaina 2023
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Pharmacokinetics of 5-Azacitidine Administered With Phenylbutyrate in Patients With Refractory Solid Tumors or Hematologic Malignancies

    Pharmacokinetics of 5-Azacitidine Administered With Phenylbutyrate in Patients With Refractory Solid Tumors or Hematologic Malignancies mā Michelle A. Rudek, Ming Zhao, Ping He, Carol Hartke, Jill Gilbert, Steven D. Gore, Michael A. Carducci, Sharyn D. Baker

    I whakaputaina 2005
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Phase I study of the histone deacetylase inhibitor entinostat in combination with 13-cis retinoic acid in patients with solid tumours

    Phase I study of the histone deacetylase inhibitor entinostat in combination with 13-cis retinoic acid in patients with solid tumours mā Роберто Пили, Brenda Salumbides, Ming Zhao, Soner Altiok, David Z. Qian, James A. Zwiebel, Michael A. Carducci, Michelle A. Rudek

    I whakaputaina 2011
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    The Optimal Dose of Prophylactic Intravenous Naloxone in Ameliorating Opioid-Induced Side Effects in Children Receiving Intravenous Patient-Controlled Analgesia Morphine for Moderate to Severe Pain

    The Optimal Dose of Prophylactic Intravenous Naloxone in Ameliorating Opioid-Induced Side Effects in Children Receiving Intravenous Patient-Controlled Analgesia Morphine for Modera... mā Constance L. Monitto, Sabine Kost‐Byerly, Elizabeth White, Carlton K.K. Lee, Michelle A. Rudek, Carol B. Thompson, Myron Yaster

    I whakaputaina 2011
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    The Rising Challenge of Non-AIDS-Defining Cancers in HIV-Infected Patients

    The Rising Challenge of Non-AIDS-Defining Cancers in HIV-Infected Patients mā John F. Deeken, A. Tjen-A-Looi, Michelle A. Rudek, Cathy Okuliar, Ming‐Lon Young, RF Little, B. J. Dezube

    I whakaputaina 2012
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Metformin Protects Cells from Mutant Huntingtin Toxicity Through Activation of AMPK and Modulation of Mitochondrial Dynamics

    Metformin Protects Cells from Mutant Huntingtin Toxicity Through Activation of AMPK and Modulation of Mitochondrial Dynamics mā Jing Jin, Hao Gu, Nicole M. Anders, Tianhua Ren, Mali Jiang, Michael Tao, Peng Qi, Michelle A. Rudek, Wenzhen Duan

    I whakaputaina 2016
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    A phase I study of MLN4924 and belinostat in relapsed/refractory acute myeloid leukemia or myelodysplastic syndrome

    A phase I study of MLN4924 and belinostat in relapsed/refractory acute myeloid leukemia or myelodysplastic syndrome mā Keri Maher, Danielle Shafer, Dale Schaar, Dipankar Bandyopadhyay, Xiaoyan Deng, John Wright, Richard Piekarz, Michelle A. Rudek, R. Donald Harvey, Steven Grant

    I whakaputaina 2025
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    A Targeting Modality for Destruction of RNA Polymerase I that Possesses Anticancer Activity

    A Targeting Modality for Destruction of RNA Polymerase I that Possesses Anticancer Activity mā Karita Peltonen, Laureen Colis, Hester Liu, Rishi Trivedi, Michael S. Moubarek, Henna M. Moore, Baoyan Bai, Michelle A. Rudek, Charles J. Bieberich, Marikki Laiho

    I whakaputaina 2014
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Pharmacodynamic study of disulfiram in men with non-metastatic recurrent prostate cancer

    Pharmacodynamic study of disulfiram in men with non-metastatic recurrent prostate cancer mā Michael Schweizer, Jianqing Lin, Amanda L. Blackford, Aditya Bardia, Samantha J. King, Andrew J. Armstrong, Michelle A. Rudek, Srinivasan Yegnasubramanian, Michael A. Carducci

    I whakaputaina 2013
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Phase I Study of ON 01910.Na, a Novel Modulator of the Polo-Like Kinase 1 Pathway, in Adult Patients With Solid Tumors

    Phase I Study of ON 01910.Na, a Novel Modulator of the Polo-Like Kinase 1 Pathway, in Adult Patients With Solid Tumors mā Antonio Jimeno, Jing Li, Wells A. Messersmith, Daniel A. Laheru, Michelle A. Rudek, Manoj Maniar, Manuel Hidalgo, Sharyn D. Baker, Ross C. Donehower

    I whakaputaina 2008
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    <i>TKTL1</i> Is Activated by Promoter Hypomethylation and Contributes to Head and Neck Squamous Cell Carcinoma Carcinogenesis through Increased Aerobic Glycolysis and HIF1α Stabilization

    <i>TKTL1</i> Is Activated by Promoter Hypomethylation and Contributes to Head and Neck Squamous Cell Carcinoma Carcinogenesis through Increased Aerobic Glycolysis and HIF1α Stabili... mā Wenyue Sun, Yan Liu, Chad A. Glazer, Chunbo Shao, Sheetal Bhan, Semra Demokan, Ming Zhao, Michelle A. Rudek, Patrick K. Ha, Joseph A. Califano

    I whakaputaina 2010
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    The effect of regadenoson-induced transient disruption of the blood–brain barrier on temozolomide delivery to normal rat brain

    The effect of regadenoson-induced transient disruption of the blood–brain barrier on temozolomide delivery to normal rat brain mā Sadhana Jackson, Nicole M. Anders, Antonella Mangraviti, Teresia Wanjiku, Eric W. Sankey, Ann Liu, Henry Brem, Betty Tyler, Michelle A. Rudek, Stuart A. Grossman

    I whakaputaina 2015
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    A phase II study of the gamma secretase inhibitor RO4929097 in patients with previously treated metastatic pancreatic adenocarcinoma

    A phase II study of the gamma secretase inhibitor RO4929097 in patients with previously treated metastatic pancreatic adenocarcinoma mā Ana De Jesus‐Acosta, Daniel A. Laheru, Anirban Maitra, John J. Arcaroli, Michelle A. Rudek, Arvind Dasari, Patrick J. Blatchford, Kevin S. Quackenbush, Wells A. Messersmith

    I whakaputaina 2014
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Phase II Trial of Imatinib in AIDS-Associated Kaposi's Sarcoma: AIDS Malignancy Consortium Protocol 042

    Phase II Trial of Imatinib in AIDS-Associated Kaposi's Sarcoma: AIDS Malignancy Consortium Protocol 042 mā Henry Koon, Susan E. Krown, Jeannette Y. Lee, Kord Honda, Suthee Rapisuwon, Zhenghe Wang, David M. Aboulafia, Erin Reid, Michelle A. Rudek, Bruce J. Dezube, Ariela Noy

    I whakaputaina 2013
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: